E!10253, CD-CARD, Diagnostic product for rapid HIV-patient testing, Getica AB
| Diarienummer | |
| Koordinator | GETICA AB - Sahlgrenska Science Park |
| Bidrag från Vinnova | 4 615 388 kronor |
| Projektets löptid | mars 2016 - augusti 2019 |
| Status | Avslutat |
| Utlysning | Eurostars – för forskande små och medelstora företag |
Syfte och mål
Measurements of CD4 receptors on the surface og lymphocytes in whole blood samples by means of flow cytometry technology is the classical method for monitoring treatment of HIV infected patients. The reagent and the equipment are expensive, and may patiens do not have access to the technologies. Getica AB has - in collaboration with Gentian AS in Norway , with Oslo University Hospital and Sahlgrenska University Hospital, developed a near patient method for said monitoring, faster and less expensive than the flow cytometry reference method.
Resultat och förväntade effekter
The project resulted in a successful calibration study in Gothenburg and successful measurements of the concentration of the concentration of the CD4 receptors in 50 patients treated for HIV infections at Oslo University Hospital. The project will will constitute the basis for optimasasion studies and adapting the methods to commercial products to be produced in Gothenburg.
Upplägg och genomförande
Oslo and Västra Götaland has well developed programs for monitoring and treatment of HIV patiens, and the result of the treatment and monitoring the patients have lead to improved prognosis for the patients. Further collaboration with the partners will lead to further commercial development of the assay technology and sales to the testing laboratories internationally.